Clinical Trial Update: Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating Roxadustat (FG-4592) for anemia in pediatric CKD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Associated with Chronic Kidney Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Anemia Associated With Chronic Kidney Disease | Phase 3 | Status: WITHDRAWN